Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development @Cosmo_Pharma #HealthCare #Appointment #OTC #OTCMarkets #OTCStocks #Investing
Dublin, Ireland--(Newsfile Corp. - September 23, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is excited to announce the appointment of Ms. Egle Gedrimaite, as the new Head of Global Business Development, effective October 1, 2024. Egle Gedrimaite will report to Giovanni Di Napoli, CEO of Cosmo. With extensive experience in expanding global business operations and driving strategic market growth, Egle is a valuable addition to Cosmo’s management team, as...
http://dlvr.it/TDYs0L
http://dlvr.it/TDYs0L
Comments
Post a Comment